Ovid Therapeutics Inc.OVIDNASDAQ
Loading
Current Ratio Over TimeNormalizing
Percentile Rank45
3Y CAGR-16.6%
5Y CAGR+26.3%
Studio
Year-over-Year Change

Current ratio (current assets / current liabilities)

3Y CAGR
-16.6%/yr
vs +39.2%/yr prior
5Y CAGR
+26.3%/yr
Recent deceleration
Acceleration
-55.8pp
Decelerating
Percentile
P45
Within normal range
vs 5Y Ago
3.2x
Strong expansion
Streak
1 yr
Consecutive growthNormalizing
PeriodValueYoY Change
202510.91+105.3%
20245.32-44.3%
20239.55-49.2%
202218.79+46.0%
202112.87+279.4%
20203.39-55.2%
20197.58+51.4%
20185.01-66.0%
201714.71+4.8%
201614.04-